查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
蛋白质体学市场－全球及区域分析：按产品、技术、应用、最终用户和地区划分－分析与预测（2025-2035）
市场调查报告书
商品编码
1856052

蛋白质体学市场－全球及区域分析：按产品、技术、应用、最终用户和地区划分－分析与预测（2025-2035）

Proteomics Market - A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Regional Analysis - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 197 Pages | 商品交期: 1-5个工作天内

价格

全球蛋白质体学市场预计到 2025 年将达到约 296 亿美元，预计到 2035 年将成长至 962.8 亿美元，复合年增长率约为 12.52%。

全球蛋白质体学市场正经历加速成长，这主要得益于慢性病和神经退化性疾病盛行率的上升、技术的不断进步以及对个人化医疗日益增长的需求。蛋白质体学已成为一个变革性领域，能够对蛋白质的结构、功能和相互作用进行深入分析，这对于阐明疾病机制和开发标靶治疗至关重要。人工智慧、机器学习和多组体学平台的整合正在革新蛋白质体学的工作流程，从生物标记的发现到临床应用，都能实现更快、更准确、更经济高效的分析。人工智慧系统正在简化数据解读，揭示复杂的蛋白质相互作用网络，并透过预测建模促进疾病的早期检测。

关键市场统计数据
预测期 2025-2035
2025 年估值 296亿美元
2035 年预测 962.8亿美元
复合年增长率 12.52%

此外，自主发现平台和生成式人工智慧工具正透过赋能研究人员以最小的人工干预迭代执行设计、测试和优化週期，加速药物发现和诊断进程。製药公司、生物技术公司和受託研究机构正日益与人工智慧主导的新兴企业和技术提供商合作，以增强扩充性、改进数据整合并实现精准主导的洞察。策略伙伴关係、资金筹措计划和併购正在加强先进蛋白质体学平台的商业化，而云端基础和本地部署解决方案则正在扩大其在研究和临床环境中的可及性。这些因素共同重塑了全球蛋白质体学市场，提高了研究效率，并为其持续的长期成长奠定了基础。

全球蛋白质体学市场生命週期阶段

全球蛋白质体学市场目前正处于生命週期的成长和加速阶段，从早期应用阶段向更广泛的市场成熟阶段过渡。过去十年，该领域已从学术探索性研究发展成为精准医疗、临床诊断和药物研发中具有战略意义的重要组成部分。这一转变得益于质谱、液相层析法和亲和层析蛋白质体学平台技术的快速发展，以及人工智慧、机器学习和多组体学分析的融合应用。

全球蛋白质体学市场的扩张得益于技术创新和临床效用的强强联合。数据非依赖性采集（DIA）方法、单细胞蛋白质组学、空间蛋白质组学以及生物资讯学流程的持续改进，使得高通量、高灵敏度的蛋白质谱分析成为可能。同时，商业性参与企业正透过自动化、云端分析和服务型交付模式，不断提昇平台的可近性。这些趋势预示着蛋白质体学正从科研应用领域迈向临床和转化应用领域迈进。

儘管市场创新强度很高，但不同地区和终端用户群的渗透率却存在差异。北美和欧洲的研发市场在製药、生物技术和学术研究生态系统中已接近主流化应用。相较之下，新兴地区的应用仍处于早期发展阶段，受到高昂的资本成本、基础设施不足和技能人才匮乏等因素的限制。这种分化使得全球市场处于中后期成长阶段，透过价格合理的设备、​​服务合作和分散式蛋白质体学网络，市场拥有庞大的扩张机会。

全球蛋白质体学市场正处于蓬勃发展阶段，其特点是技术创新、资本流入和终端用户应用日益普及。未来几年，随着临床应用的进一步整合、工作流程的标准化以及技术提供者之间的整合，该产业预计将逐步成熟。

市场区隔

细分1：按产品

  • 样品製备
  • 蛋白质体学技术
    • 试剂和耗材
    • 装置
    • 软体
  • 蛋白质体学服务

蛋白质体学技术领域预计将占据全球蛋白质体学市场最大的份额。这主要归功于质谱仪、层析法系统和专用软体等先进分析平台的广泛应用，这些平台为进行高通量、高解析度蛋白质组学分析奠定了基础。仪器技术的持续创新、对平台特异性试剂日益增长的需求以及人工智慧和云端基础工具的日益融合，进一步巩固了该领域的领先地位。此外，蛋白质体学技术相关的高额资本支出也显着提升了整体市场价值。

细分2：依技术

  • 基于质谱的蛋白质体学
  • 基于层析法的蛋白质体学
  • 蛋白质微阵列
  • 单细胞蛋白质体学
  • 基于NGS的蛋白质体学
  • 其他的

从技术角度来看，基于质谱的蛋白质体学预计将在2024年主导全球蛋白质体学市场，这主要归功于其在识别和定量各种生物样本中的蛋白质方面无与伦比的灵敏度、准确性和多功能性。质谱技术已成为蛋白质体学研究的黄金标准，因为它能够支援发现和靶向工作流程，检测转译后修饰，并处理复杂的样本基质。其在临床和转化研究中的应用进一步推动了其在製药、学术和诊断领域的普及。

细分3：按应用

  • 生物标记的发现与检验
  • 蛋白质体分析与作图
  • 药物发现与开发
    • 药物发现
    • 临床前试验
    • 临床试验
  • 伴随诊断
  • 蛋白质-蛋白质相互作用

预计到2024年，生物标记发现和检验领域将占据全球蛋白质体学市场最大的份额。这一主导地位源于其在多个治疗领域的广泛应用、在精准医疗中的关键作用，以及由于其在早期研究、诊断和药物开发中的作用而获得的巨额资金。蛋白质体学的广泛应用及其对各种蛋白质体学技术的依赖，使其成为最受追捧的应用领域。

细分 4：按最终用户

  • 学术和研究机构
  • 製药和生物技术公司
  • 临床诊断实验室和医院
  • 受託研究机构

根据终端用户细分，预计到2024年，学术和研究机构将占据全球蛋白质体学市场最大的份额。这主要归功于大学、政府资助的实验室和公共研究中心所进行的大量基础研究和转化研究。这些研究机构处于新型蛋白质组学方法、生物标记发现和系统生物学领域的前沿，并通常获得大量的公共和私人资金支持。此外，先进的基础设施、与产业相关人员的合作以及对创新的高度重视，使学术和研究机构成为全球蛋白质体学应用的关键驱动力。

细分5：按地区

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

预计北美将在2024年占据全球蛋白质体学市场最大份额，达到44.69%。这一主导地位归功于该地区完善的研究基础设施、主要市场参与企业的强大实力、对生命科学研发的高额投入，以及先进蛋白质体学技术在学术界和临床领域的广泛应用。同时，亚太地区预计将成为成长最快的地区，在预测期（2025-2035年）内将实现13.86%的复合年增长率。这主要得益于政府对生物医学研究投入的不断增加、医疗基础设施的快速扩张、对精准医疗日益重视，以及全球企业与区域研究机构之间合作的日益密切。

需求——驱动因素与限制因素

全球蛋白质体学市场需求驱动因素：

  • 慢性病盛行率不断上升
  • 持续的技术进步
  • 对个人化医疗的需求日益增长

全球蛋白质体学市场限制：

  • 高昂的购置成本阻碍了蛋白质体学技术的应用。
  • 熟练专业人员短缺

本报告旨在帮助企业识别全球蛋白质体学市场中的高价值机会。它指南研发投资策略、技术应用和产品线优化，帮助倡议优先推广生物标记发现、疾病诊断和治疗药物开发。透过重点介绍新兴技术、策略合作伙伴关係和平台扩充性，本报告助力企业获得竞争优势，并充分利用蛋白质体学在研究、临床和製药领域的快速发展。

本报告深入分析了区域市场采纳趋势、新兴市场和伙伴关係机会，旨在为企业製定策略性市场进入和商业化规划提供支援。企业可以藉此识别产品、技术、应用和终端用户等各个细分市场的成长潜力。了解区域研发投入、法规结构和技术采纳率，有助于企业优化行销、授权和合作策略，从而在全球竞争激烈的市场环境中最大限度地提升品牌知名度和投资回报率。

本报告提供全面的公司概况、竞争基准化分析、策略联盟亮点、资金筹措活动、併购以及技术应用趋势。相关人员可以清楚了解竞争对手的关注领域、研发重点和市场定位。这些资讯有助于企业识别差距、预测市场变化、实现差异化、优化市场进入策略，并制定策略以保持在蛋白质体学生态系统中的领先地位。

主要市场参与企业和竞争格局

全球蛋白质体学市场竞争激烈，老字型大小企业企业和新兴企业企业均积极参与其中，市场格局不断演变。主要参与企业包括生命科学仪器、耗材和生物资讯解决方案的领先供应商，以及提供质谱、蛋白质微阵列、层析法系统和数据分析平台等尖端技术的服务供应商。主要企业包括：

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carterra, Inc.
  • Danaher Corporation
  • DiaSorin SPA
  • Erisyon Inc.
  • Illumina, Inc.
  • RareCyte Inc.
  • Quanterix Corporation
  • Quantum-Si Incorporated
  • Shimadzu Corporation
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

竞争基准化分析着重于併购、资金筹措活动、授权合约和医药合作，体现了对创新和快速上市的日益重视。评估标准包括公司的市场占有率、技术能力、策略倡议和产品系列。详细的公司概况涵盖目标终端使用者、技术重点领域和专家分析师的观点，为相关人员提供有关投资机会、市场定位和策略成长路径的可操作性见解。这些资讯有助于公司有效地调整其研发和商业化策略，以适应全球蛋白质体学市场的新兴市场动态。

目录

执行摘要

第一章 市场：产业展望

  • 市场概览与生态系统
  • 与其他体学相比，蛋白质体学的比较优势和劣势
  • 供应链分析
  • 市场动态
  • 趋势
    • 加速端到端蛋白质体学工作流程的自动化
    • 拓展蛋白质体学研究以识别疾病生物标记
    • 市场参与企业之间的众多合作
  • 市场动态
  • 监管状态/合规性
    • 美国
    • 欧洲
    • 其他地区
  • 专利分析
  • 产品基准测试

第二章 供品

  • 招股摘要
  • 全球蛋白质体学市场按产品/服务划分
    • 样品製备
    • 蛋白质体学技术
    • 蛋白质体学服务

第三章 应用

  • 使用摘要
  • 全球蛋白质体学市场（按应用领域划分）
    • 生物标记的发现与检验
    • 蛋白质体分析与作图
    • 药物发现与开发
    • 伴随诊断
    • 蛋白质-蛋白质相互作用

第四章 技术

  • 技术摘要
  • 全球蛋白质体学市场（按技术划分）
    • 基于质谱的蛋白质体学
    • 基于层析法的蛋白质体学
    • 蛋白质微阵列
    • 单细胞蛋白质体学
    • 基于NGS的蛋白质体学
    • 其他的

第五章 最终用户

  • 最终用户摘要
  • 全球蛋白质体学市场（按最终用户划分）
    • 学术研究机构
    • 製药和生物技术公司
    • 医院和临床诊断实验室
    • CRO

第六章 区域

  • 区域摘要
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

7. 市场－竞争基准化分析与公司概况

  • 公司简介
    • Agilent Technologies, Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Carterra, Inc.
    • Danaher Corporation
    • DiaSorin SPA
    • Erisyon Inc.
    • Illumina, Inc.
    • RareCyte Inc.
    • Quanterix Corporation
    • Quantum-Si Incorporated
    • Shimadzu Corporation
    • Standard BioTools Inc.
    • Thermo Fisher Scientific Inc.
    • Waters Corporation

第八章调查方法

Product Code: BHP1781SB

This report can be delivered within 1 working day.

Global Proteomics Market: Industry Overview

The global proteomics market was valued at approximately $29.60 billion in 2025 and is projected to grow $96.28 billion by 2035, at a CAGR of around 12.52%. The global proteomics market is witnessing accelerated growth driven by the rising prevalence of chronic and neurodegenerative diseases, continuous technological advancements, and the increasing demand for personalized medicine. Proteomics has emerged as a transformative field, enabling in-depth analysis of protein structures, functions, and interactions, which are critical for understanding disease mechanisms and developing targeted therapies. The integration of artificial intelligence, machine learning, and multi-omics platforms is revolutionizing the proteomics workflow, from biomarker discovery to clinical translation, by enabling faster, more accurate, and cost-effective analyses. AI-enabled systems are streamlining data interpretation, uncovering complex protein interaction networks, and facilitating early disease detection through predictive modeling.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$29.60 Billion
2035 Forecast$96.28 Billion
CAGR12.52%

Moreover, autonomous discovery platforms and generative AI tools are empowering researchers to perform iterative design, test, and optimize cycles with minimal human intervention, accelerating drug discovery and diagnostics. Pharmaceutical, biotechnology, and contract research organizations are increasingly collaborating with AI-driven startups and technology providers to enhance scalability, improve data integration, and enable precision-driven insights. Strategic partnerships, funding initiatives, and mergers are strengthening the commercialization of advanced proteomic platforms, while cloud-based and on-premise solutions are expanding accessibility across research and clinical settings. Collectively, these factors are reshaping the global proteomics landscape, improving research productivity, and positioning the market for sustained long-term growth.

Global Proteomics Market Lifecycle Stage

The global proteomics market currently stands at the growth and acceleration stage of its lifecycle, transitioning from early adoption toward broader market maturity. Over the past decade, the field has evolved from academic and exploratory research into a strategically critical component of precision medicine, clinical diagnostics, and drug discovery. This shift has been fueled by rapid advancements in mass spectrometry, liquid chromatography, and affinity-based proteomic platforms, alongside the integration of artificial intelligence, machine learning, and multi-omics analytics.

The expansion of the global proteomics market is underpinned by a robust convergence of technological innovation and clinical utility. Continuous improvements in data-independent acquisition (DIA) methods, single-cell and spatial proteomics, and bioinformatics pipelines are enabling high-throughput, high-sensitivity protein profiling. At the same time, commercial players are scaling platform accessibility through automation, cloud-enabled analytics, and service-based delivery models. These trends indicate strong forward momentum as proteomics moves beyond research applications into clinical and translational domains.

While the market exhibits high innovation intensity, its penetration remains uneven across regions and end-user segments. Developed markets in North America and Europe demonstrate near-mainstream adoption within pharma, biotech, and academic research ecosystems. Conversely, adoption in emerging regions is still in its early growth phase, constrained by high capital costs, infrastructure gaps, and limited skilled personnel. This bifurcation positions the market globally within a mid-to-late growth phase, with significant opportunities for expansion through affordable instrumentation, service partnerships, and decentralized proteomic networks.

In summary, the global proteomics market is in a dynamic growth stage, characterized by technological disruption, capital inflows, and expanding end-user adoption. Over the next few years, the industry is expected to move toward early maturity, with broader clinical integration, standardization of workflows, and consolidation among technology providers.

Market Segmentation:

Segmentation 1: By Offering

  • Sample Preparation
  • Proteomics Technologies
    • Reagents and Consumables
    • Instruments
    • Software
  • Proteomics Services

Proteomics technologies segment is expected to account for the largest share of the global proteomics market. This can be attributed to the widespread adoption of advanced analytical platforms, including mass spectrometry, chromatography systems, and specialized software, which are fundamental to conducting high-throughput and high-resolution proteomic analyses. The continuous innovation in instrumentation, growing demand for platform-specific reagents, and increasing integration of AI and cloud-based tools have further strengthened the dominance of this segment. Additionally, the high capital investment associated with proteomic technologies contributes significantly to overall market value.

Segmentation 2: By Technology

  • Mass Spectrometry-Based Proteomics
  • Chromatography-Based Proteomics
  • Protein Microarrays
  • Single-Cell Proteomics
  • NGS-Based Proteomics
  • Others

Based on technology, mass spectrometry-based proteomics is expected to dominate the global proteomics market in 2024. This is primarily due to its unmatched sensitivity, accuracy, and versatility in identifying and quantifying proteins across diverse biological samples. Mass spectrometry has become the gold standard in proteomic research owing to its ability to support both discovery and targeted workflows, detect post-translational modifications, and handle complex sample matrices. Its integration into clinical and translational research has further expanded its adoption across pharmaceutical, academic, and diagnostic settings.

Segmentation 3: By Application

  • Biomarker Discovery and Validation
  • Proteome Profiling and Mapping
  • Drug Discovery and Development
    • Discovery
    • Preclinical
    • Clinical
  • Companion Diagnostics
  • Protein-Protein Interactions

In 2024, biomarker discovery and validation segment is projected to hold the largest share of the global proteomics market. This dominance is driven by its wide usage across multiple therapeutic areas, integral to precision medicine, and heavily funded for its role in early-stage research, diagnostics, and drug development. Its broad applicability and reliance on diverse proteomics technologies make it the most in-demand application

Segmentation 4: By End User

  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Clinical Diagnostic Laboratory & Hospitals
  • Contract Research Organizations

Based on end-user segmentation, academic and research institutions are expected to account for the largest share of the global proteomics market in 2024. This is primarily driven by the high volume of basic and translational research activities conducted in universities, government-funded laboratories, and public research centers. These institutions are at the forefront of exploring novel proteomic methodologies, biomarker discovery, and systems biology, often supported by significant public and private funding. Additionally, the availability of advanced infrastructure, collaborations with industry players, and a strong focus on innovation have positioned academic and research institutions as key drivers of proteomics adoption globally.

Segmentation 5: By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Based on region, North America is expected to hold the largest share of the global proteomics market in 2024, accounting for 44.69%. This dominance is attributed to the region's well-established research infrastructure, strong presence of key market players, high investment in life sciences R&D, and widespread adoption of advanced proteomic technologies in both academic and clinical settings. Meanwhile, Asia-Pacific is projected to be the fastest-growing region during the forecast period (2025-2035), with a CAGR of 13.86%, driven by increasing government funding for biomedical research, rapid expansion of healthcare infrastructure, growing focus on precision medicine, and a rising number of collaborations between global companies and regional research institutions.

Demand - Drivers and Limitations

Demand Drivers for the Global Proteomics Market:

  • Rising Prevalence of Chronic Diseases
  • Continuous Technological Advancements
  • Increasing Demand for Personalized Medicine

Limitations for the Global Proteomics Market:

  • High Costs of Acquisition Hindering the Adoption of Proteomics Technologies
  • Shortage of Skilled Professionals

How can this report add value to an organization?

Product/Innovation: This report enables organizations to identify high-value opportunities in the global proteomics market. It guides R&D investment strategies, technology adoption, and pipeline optimization, helping companies prioritize initiatives that accelerate biomarker discovery, disease diagnostics, and therapeutic development. By highlighting emerging technologies, strategic collaborations, and platform scalability, this report helps organizations strengthen their competitive positioning and capitalize on the rapid expansion of proteomics across research, clinical, and pharmaceutical applications.

Growth/Marketing: The report delivers in-depth insights into regional adoption trends, emerging markets, and partnership opportunities, supporting strategic market entry and commercialization planning. It enables companies to identify growth potential across offering, technology, application, and end-user segments. By understanding regional R&D investments, regulatory frameworks, and technology adoption rates, organizations can refine marketing, licensing, and collaboration strategies, maximize visibility, and increase return on investment in a competitive global landscape.

Competitive: This report provides comprehensive company profiling, competitive benchmarking, highlighting strategic collaborations, funding activities, mergers, acquisitions, and technology adoption trends. Stakeholders gain a clear understanding of competitor focus areas, R&D priorities, and market positioning. This intelligence allows organizations to identify gaps, anticipate market shifts, and formulate strategies to differentiate themselves, optimize market entry, and maintain leadership in the proteomics ecosystem.

Key Market Players and Competitive Landscape

The global proteomics market is characterized by a highly competitive and evolving landscape, with participation from both well-established and emerging start-up companies. The key players include leading providers of life science instruments, consumables, and bioinformatics solutions offering advanced technologies such as mass spectrometry, protein microarrays, chromatography systems, and data analysis platforms as well as service providers. Key players include:

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carterra, Inc.
  • Danaher Corporation
  • DiaSorin S.P.A.
  • Erisyon Inc.
  • Illumina, Inc.
  • RareCyte Inc.
  • Quanterix Corporation
  • Quantum-Si Incorporated
  • Shimadzu Corporation
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

Competitive benchmarking highlights mergers and acquisitions, funding activities, licensing deals, and collaborations with pharmaceutical organizations, reflecting the growing emphasis on innovation and speed-to-market. Companies are evaluated based on market presence, technological capabilities, strategic initiatives, and product portfolios. Detailed company profiles cover target end users, technological focus areas, and expert analyst perspectives, providing stakeholders with actionable insights into investment opportunities, market positioning, and strategic growth pathways. This intelligence enables organizations to effectively align their R&D and commercialization strategies with emerging market dynamics of the global proteomics market.

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Overview and Ecosystem
  • 1.2 Comparative Advantages and Disadvantages of Proteomics Over Other Omics
  • 1.3 Supply Chain Analysis
  • 1.4 Market Dynamics
    • 1.4.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment, 2024-2035
  • 1.5 Trends
    • 1.5.1 Increasing Automation for End-to-End Proteomics Workflow
    • 1.5.2 Growing Proteomics Research to Identify Disease Biomarkers
    • 1.5.3 Significant Number of Collaborations among Market Players
  • 1.6 Market Dynamics
    • 1.6.1 Market Drivers
      • 1.6.1.1 Rising Prevalence of Chronic Diseases
      • 1.6.1.2 Continuous Technological Advancements
      • 1.6.1.3 Increasing Demand for Personalized Medicine
    • 1.6.2 Market Challenges
      • 1.6.2.1 High Costs of Acquisition Hindering the Adoption of Proteomics Technologies
      • 1.6.2.2 Shortage of Skilled Professionals
    • 1.6.3 Business Strategies
      • 1.6.3.1 Key Product Launch/Expansion
    • 1.6.4 Corporate Strategies
      • 1.6.4.1 Key Partnerships
      • 1.6.4.2 Key Funding and Grants
      • 1.6.4.3 Key Merger and Acquisitions
    • 1.6.5 Market Opportunities
      • 1.6.5.1 Expanding Proteomics Market in Emerging Regions through Affordable Technologies
  • 1.7 Regulatory Landscape/Compliance
    • 1.7.1 U.S.
      • 1.7.1.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
      • 1.7.1.2 Regulatory Requirements for Research Use Only (RUO) Products
      • 1.7.1.3 Requirements under the Clinical Laboratory Improvement Amendments (CLIA) for Clinical Proteomics Labs
    • 1.7.2 Europe
      • 1.7.2.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
        • 1.7.2.1.1 EU Medical Device Regulation
        • 1.7.2.1.2 EU In Vitro Diagnostic Regulation
        • 1.7.2.1.3 Regulatory Requirements for Clinical Proteomics Labs in the EU
    • 1.7.3 Rest-of-the-World
      • 1.7.3.1 China
        • 1.7.3.1.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
      • 1.7.3.2 Japan
        • 1.7.3.2.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
      • 1.7.3.3 Brazil
        • 1.7.3.3.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
        • 1.7.3.3.2 Regulatory Requirements for Clinical Proteomics Labs in Brazil
  • 1.8 Patent Analysis
    • 1.8.1 Patent Analysis (by Year)
    • 1.8.2 Patent Analysis (by Country)
  • 1.9 Product Benchmarking

2 Offering

  • 2.1 Offering Summary
  • 2.2 Global Proteomics Market (by Offering)
    • 2.2.1 Sample Preparation
    • 2.2.2 Proteomics Technologies
      • 2.2.2.1 Reagents and Consumables
        • 2.2.2.1.1 MS-Based Reagents
        • 2.2.2.1.2 Chromatography-Based Reagents
        • 2.2.2.1.3 Protein Microarray Reagents
        • 2.2.2.1.4 Single-Cell Analysis Reagents
        • 2.2.2.1.5 NGS-Based Reagents
        • 2.2.2.1.6 Other Reagents
      • 2.2.2.2 Instruments
        • 2.2.2.2.1 Mass Spectrometers
        • 2.2.2.2.2 Chromatography Systems
        • 2.2.2.2.3 Protein Microarrays
        • 2.2.2.2.4 Single-Cell Analysis Instruments
        • 2.2.2.2.5 NGS Instruments
        • 2.2.2.2.6 Other Instruments
      • 2.2.2.3 Software
        • 2.2.2.3.1 AI-Based Proteomics Analysis Tools
        • 2.2.2.3.2 Spatial Proteomics Data Analytic Software
        • 2.2.2.3.3 Cloud-Based Platforms
    • 2.2.3 Proteomics Services

3 Application

  • 3.1 Application Summary
  • 3.2 Global Proteomics Market (by Application)
    • 3.2.1 Biomarker Discovery and Validation
    • 3.2.2 Proteome Profiling and Mapping
    • 3.2.3 Drug Discovery and Development
      • 3.2.3.1 Discovery
        • 3.2.3.1.1 Target Identification and Validation
        • 3.2.3.1.2 Others
      • 3.2.3.2 Preclinical
      • 3.2.3.3 Clinical
    • 3.2.4 Companion Diagnostics
    • 3.2.5 Protein-Protein Interactions

4 Technology

  • 4.1 Technology Summary
  • 4.2 Global Proteomics Market (by Technology)
    • 4.2.1 Mass Spectrometry-Based Proteomics
    • 4.2.2 Chromatography-Based Proteomics
    • 4.2.3 Protein Microarray
    • 4.2.4 Single-Cell Proteomics
    • 4.2.5 NGS-Based Proteomics
    • 4.2.6 Other Technologies

5 End User

  • 5.1 End User Summary
  • 5.2 Global Proteomics Market (by End User)
    • 5.2.1 Academic and Research Institutions
    • 5.2.2 Pharmaceutical and Biotechnology Companies
    • 5.2.3 Hospitals and Clinical Diagnostics Laboratories
    • 5.2.4 Contract Research Organizations

6 Region

  • 6.1 Regional Summary
  • 6.2 North America
    • 6.2.1 Regional Overview
    • 6.2.2 Driving Factors for Market Growth
    • 6.2.3 Factors Challenging the Market
    • 6.2.4 By Offering
      • 6.2.4.1 By Proteomics Technologies
    • 6.2.5 By Application
    • 6.2.6 By Country
      • 6.2.6.1 U.S.
        • 6.2.6.1.1 By Offering
        • 6.2.6.1.2 Application
      • 6.2.6.2 Canada
        • 6.2.6.2.1 By Offering
        • 6.2.6.2.2 By Application
  • 6.3 Europe
    • 6.3.1 Regional Overview
    • 6.3.2 Driving Factors for Market Growth
    • 6.3.3 Factors Challenging the Market
    • 6.3.4 By Offering
      • 6.3.4.1 By Proteomics Technologies
    • 6.3.5 By Application
    • 6.3.6 By Country
      • 6.3.6.1 U.K.
        • 6.3.6.1.1 By Offering
        • 6.3.6.1.2 By Application
      • 6.3.6.2 Germany
        • 6.3.6.2.1 By Offering
        • 6.3.6.2.2 By Application
      • 6.3.6.3 France
        • 6.3.6.3.1 By Offering
        • 6.3.6.3.2 By Application
      • 6.3.6.4 Italy
        • 6.3.6.4.1 By Offering
        • 6.3.6.4.2 By Application
      • 6.3.6.5 Spain
        • 6.3.6.5.1 By Offering
        • 6.3.6.5.2 By Application
      • 6.3.6.6 Rest-of-Europe
        • 6.3.6.6.1 By Offering
        • 6.3.6.6.2 By Application
  • 6.4 Asia-Pacific
    • 6.4.1 Regional Overview
    • 6.4.2 Driving Factors for Market Growth
    • 6.4.3 Factors Challenging the Market
    • 6.4.4 By Offering
      • 6.4.4.1 By Proteomics Technologies
    • 6.4.5 By Application
    • 6.4.6 By Country
      • 6.4.6.1 Japan
        • 6.4.6.1.1 By Offering
        • 6.4.6.1.2 By Application
      • 6.4.6.2 China
        • 6.4.6.2.1 By Offering
        • 6.4.6.2.2 Application
      • 6.4.6.3 India
        • 6.4.6.3.1 By Offering
        • 6.4.6.3.2 By Application
      • 6.4.6.4 Australia
        • 6.4.6.4.1 By Offering
        • 6.4.6.4.2 By Application
      • 6.4.6.5 South Korea
        • 6.4.6.5.1 By Offering
        • 6.4.6.5.2 By Application
      • 6.4.6.6 Rest-of-Asia-Pacific
        • 6.4.6.6.1 By Offering
        • 6.4.6.6.2 By Application
  • 6.5 Latin America
    • 6.5.1 Regional Overview
    • 6.5.2 Driving Factors for Market Growth
    • 6.5.3 Factors Challenging the Market
    • 6.5.4 By Offering
      • 6.5.4.1 By Proteomics Technologies
    • 6.5.5 By Application
    • 6.5.6 By Country
      • 6.5.6.1 Brazil
        • 6.5.6.1.1 By Offering
        • 6.5.6.1.2 By Application
      • 6.5.6.2 Mexico
        • 6.5.6.2.1 By Offering
        • 6.5.6.2.2 By Application
      • 6.5.6.3 Rest-of-Latin America
        • 6.5.6.3.1 By Offering
        • 6.5.6.3.2 By Application
  • 6.6 Middle East and Africa
    • 6.6.1 Regional Overview
    • 6.6.2 Driving Factors for Market Growth
    • 6.6.3 Factors Challenging the Market
    • 6.6.4 By Offering
      • 6.6.4.1 By Proteomics Technologies
    • 6.6.5 By Application

7 Markets - Competitive Benchmarking & Company Profiles

  • 7.1 Company Profiles
    • 7.1.1 Agilent Technologies, Inc.
      • 7.1.1.1 Overview
      • 7.1.1.2 Top Products/Product Portfolio
      • 7.1.1.3 Top Competitors
      • 7.1.1.4 Target Customers
      • 7.1.1.5 Key Personal
      • 7.1.1.6 Analyst View
    • 7.1.2 Becton, Dickinson and Company
      • 7.1.2.1 Overview
      • 7.1.2.2 Top Products/Product Portfolio
      • 7.1.2.3 Top Competitors
      • 7.1.2.4 Target Customers
      • 7.1.2.5 Key Personal
      • 7.1.2.6 Analyst View
    • 7.1.3 Bio-Rad Laboratories, Inc.
      • 7.1.3.1 Overview
      • 7.1.3.2 Top Products/Product Portfolio
      • 7.1.3.3 Top Competitors
      • 7.1.3.4 Target Customers
      • 7.1.3.5 Key Personal
      • 7.1.3.6 Analyst View
    • 7.1.4 Bruker Corporation
      • 7.1.4.1 Overview
      • 7.1.4.2 Top Products/Product Portfolio
      • 7.1.4.3 Top Competitors
      • 7.1.4.4 Target Customers
      • 7.1.4.5 Key Personal
      • 7.1.4.6 Analyst View
    • 7.1.5 Carterra, Inc.
      • 7.1.5.1 Overview
      • 7.1.5.2 Top Products/Product Portfolio
      • 7.1.5.3 Top Competitors
      • 7.1.5.4 Target Customers
      • 7.1.5.5 Key Personal
      • 7.1.5.6 Analyst View
    • 7.1.6 Danaher Corporation
      • 7.1.6.1 Overview
      • 7.1.6.2 Top Products/Product Portfolio
      • 7.1.6.3 Top Competitors
      • 7.1.6.4 Target Customers
      • 7.1.6.5 Key Personal
      • 7.1.6.6 Analyst View
    • 7.1.7 DiaSorin S.P.A.
      • 7.1.7.1 Overview
      • 7.1.7.2 Top Products/Product Portfolio
      • 7.1.7.3 Top Competitors
      • 7.1.7.4 Target Customers
      • 7.1.7.5 Key Personal
      • 7.1.7.6 Analyst View
    • 7.1.8 Erisyon Inc.
      • 7.1.8.1 Overview
      • 7.1.8.2 Top Products/Product Portfolio
      • 7.1.8.3 Top Competitors
      • 7.1.8.4 Target Customers
      • 7.1.8.5 Key Personal
      • 7.1.8.6 Analyst View
      • 7.1.8.7 Market Share, 2023
    • 7.1.9 Illumina, Inc.
      • 7.1.9.1 Overview
      • 7.1.9.2 Top Products/Product Portfolio
      • 7.1.9.3 Top Competitors
      • 7.1.9.4 Target Customers
      • 7.1.9.5 Key Personal
      • 7.1.9.6 Analyst View
    • 7.1.10 RareCyte Inc.
      • 7.1.10.1 Overview
      • 7.1.10.2 Top Products/Product Portfolio
      • 7.1.10.3 Top Competitors
      • 7.1.10.4 Target Customers
      • 7.1.10.5 Key Personal
      • 7.1.10.6 Analyst View
    • 7.1.11 Quanterix Corporation
      • 7.1.11.1 Overview
      • 7.1.11.2 Top Competitors
      • 7.1.11.3 Target Customers
      • 7.1.11.4 Key Personal
      • 7.1.11.5 Analyst View
      • 7.1.11.6 Market Share, 2023
    • 7.1.12 Quantum-Si Incorporated
      • 7.1.12.1 Overview
      • 7.1.12.2 Top Products/Product Portfolio
      • 7.1.12.3 Top Competitors
      • 7.1.12.4 Target Customers
      • 7.1.12.5 Key Personal
      • 7.1.12.6 Analyst View
    • 7.1.13 Shimadzu Corporation
      • 7.1.13.1 Overview
      • 7.1.13.2 Top Products/Product Portfolio
      • 7.1.13.3 Top Competitors
      • 7.1.13.4 Target Customers
      • 7.1.13.5 Key Personal
      • 7.1.13.6 Analyst View
    • 7.1.14 Standard BioTools Inc.
      • 7.1.14.1 Overview
      • 7.1.14.2 Top Products/Product Portfolio
      • 7.1.14.3 Top Competitors
      • 7.1.14.4 Target Customers
      • 7.1.14.5 Key Personal
      • 7.1.14.6 Analyst View
    • 7.1.15 Thermo Fisher Scientific Inc.
      • 7.1.15.1 Overview
      • 7.1.15.2 Top Products/Product Portfolio
      • 7.1.15.3 Top Competitors
      • 7.1.15.4 Target Customers
      • 7.1.15.5 Key Personal
      • 7.1.15.6 Analyst View
    • 7.1.16 Waters Corporation
      • 7.1.16.1 Overview
      • 7.1.16.2 Top Products/Product Portfolio
      • 7.1.16.3 Top Competitors
      • 7.1.16.4 Target Customers
      • 7.1.16.5 Key Personal
      • 7.1.16.6 Analyst View

8 Research Methodology

  • 8.1 Data Sources
    • 8.1.1 Primary Data Sources
    • 8.1.2 Secondary Data Sources
    • 8.1.3 Data Triangulation
  • 8.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Proteomics Market (by Scenario), $Billion, 2024, 2030, and 2035
  • Figure 2: Global Proteomics Market, $Billion, 2024 and 2035
  • Figure 3: Global Proteomics Market (by Offering), $Billion, 2024, 2030, and 2035
  • Figure 4: Global Proteomics Market (by Application), $Billion, 2024, 2030, and 2035
  • Figure 5: Global Proteomics Market (by Technology), $Billion, 2024, 2030, and 2035
  • Figure 6: Global Proteomics Market (by End User), $Billion, 2024, 2030, and 2035
  • Figure 7: Global Proteomics Market Segmentation
  • Figure 8: Ecosystem Global Proteomics Market
  • Figure 9: Supply Chain and Risks within the Supply Chain
  • Figure 10: Global Proteomics Market, Patent Analysis (by Year), January 2021-December 2024
  • Figure 11: Global Proteomics Market, Patent Analysis (by Country), January 2021-December 2024
  • Figure 12: Global Proteomics Market (by Offering), $Billion, 2024, 2030, and 2035
  • Figure 13: Global Proteomics Market (Sample Preparation), $Billion, 2024-2035
  • Figure 14: Global Proteomics Market (Proteomics Technologies), $Billion, 2024-2035
  • Figure 15: Global Proteomics Market (by Proteomics Technologies, Reagents and Consumables), $Billion, 2024-2035
  • Figure 16: Global Proteomics Market (by Reagents and Consumables, MS-Based Reagents), $Billion, 2024-2035
  • Figure 17: Global Proteomics Market (by Reagents and Consumables, Chromatography-Based Reagents), $Billion, 2024-2035
  • Figure 18: Global Proteomics Market (by Reagents and Consumables, Protein Microarray Reagents), $Billion, 2024-2035
  • Figure 19: Global Proteomics Market (by Reagents and Consumables, Single-Cell Analysis Reagents), $Billion, 2024-2035
  • Figure 20: Global Proteomics Market (by Reagents and Consumables, NGS-Based Reagents), $Billion, 2024-2035
  • Figure 21: Global Proteomics Market (by Reagents and Consumables, Other Reagents), $Billion, 2024-2035
  • Figure 22: Global Proteomics Market (by Proteomics Technologies, Instruments), $Billion, 2024-2035
  • Figure 23: Global Proteomics Market (by Instruments, Mass Spectrometers), $Billion, 2024-2035
  • Figure 24: Global Proteomics Market (by Instruments, Chromatography Systems), $Billion, 2024-2035
  • Figure 25: Global Proteomics Market (by Instruments, Protein Microarrays), $Billion, 2024-2035
  • Figure 26: Global Proteomics Market (by Instruments, Single-Cell Analysis Instruments), $Billion, 2024-2035
  • Figure 27: Global Proteomics Market (by Instruments, NGS Instruments), $Billion, 2024-2035
  • Figure 28: Global Proteomics Market (by Instruments, Other Instruments), $Billion, 2024-2035
  • Figure 29: Global Proteomics Market (by Proteomics Technologies, Software), $Billion, 2024-2035
  • Figure 30: Global Proteomics Market (by Software, AI-Based Proteomics Analysis Tools), $Billion, 2024-2035
  • Figure 31: Global Proteomics Market (by Software, Spatial Proteomics Data Analytic Software), $Billion, 2024-2035
  • Figure 32: Global Proteomics Market (by Software, Cloud-Based Platforms), $Billion, 2024-2035
  • Figure 33: Global Proteomics Market (Proteomics Services), $Billion, 2024-2035
  • Figure 34: Global Proteomics Market (by Application), $Billion, 2024, 2030, and 2035
  • Figure 35: Global Proteomics Market (Biomarker Discovery and Validation), $Billion, 2024-2035
  • Figure 36: Global Proteomics Market (Proteomics Profiling and Mapping), $Billion, 2024-2035
  • Figure 37: Global Proteomics Market (Drug Discovery and Development), $Billion, 2024-2035
  • Figure 38: Global Proteomics Market (by Drug Discovery and Development, Discovery), $Billion, 2024-2035
  • Figure 39: Global Proteomics Market (by Discovery, Target Identification and Validation), $Billion, 2024-2035
  • Figure 40: Global Proteomics Market (by Discovery, Others), $Billion, 2024-2035
  • Figure 41: Global Proteomics Market (by Drug Discovery and Development, Preclinical), $Billion, 2024-2035
  • Figure 42: Global Proteomics Market (by Drug Discovery and Development, Clinical), $Billion, 2024-2035
  • Figure 43: Global Proteomics Market (Companion Diagnostics), $Billion, 2024-2035
  • Figure 44: Global Proteomics Market (Protein-Protein Interactions), $Billion, 2024-2035
  • Figure 45: Global Proteomics Market (by Technology), $Billion, 2024, 2030, and 2035
  • Figure 46: Global Proteomics Market (Mass Spectrometry-Based Proteomics), $Billion, 2024-2035
  • Figure 47: Global Proteomics Market (Chromatography-Based Proteomics), $Billion, 2024-2035
  • Figure 48: Global Proteomics Market (Protein Microarray), $Billion, 2024-2035
  • Figure 49: Global Proteomics Market (Single-Cell Proteomics), $Billion, 2024-2035
  • Figure 50: Global Proteomics Market (NGS-Based Proteomics), $Billion, 2024-2035
  • Figure 51: Global Proteomics Market (Other Technologies), $Billion, 2024-2035
  • Figure 52: Global Proteomics Market (by Application), $Billion, 2024, 2030, and 2035
  • Figure 53: Global Proteomics Market (Academic and Research Institutions), $Billion, 2024-2035
  • Figure 54: Global Proteomics Market (Pharmaceutical and Biotechnology Companies), $Billion, 2024-2035
  • Figure 55: Global Proteomics Market (Hospitals and Clinical Diagnostics Laboratories), $Billion, 2024-2035
  • Figure 56: Global Proteomics Market (Contract Research Organizations), $Billion, 2024-2035
  • Figure 57: U.S. Proteomics Market, $Billion, 2024-2035
  • Figure 58: Canada Proteomics Market, $Billion, 2024-2035
  • Figure 59: U.K. Proteomics Market, $Billion, 2024-2035
  • Figure 60: Germany Proteomics Market, $Billion, 2024-2035
  • Figure 61: France Proteomics Market, $Billion, 2024-2035
  • Figure 62: Italy Proteomics Market, $Billion, 2024-2035
  • Figure 63: Spain Proteomics Market, $Billion, 2024-2035
  • Figure 64: Rest-of-Europe Proteomics Market, $Billion, 2024-2035
  • Figure 65: Japan Proteomics Market, $Billion, 2024-2035
  • Figure 66: China Proteomics Market, $Billion, 2024-2035
  • Figure 67: India Proteomics Market, $Billion, 2024-2035
  • Figure 68: Australia Proteomics Market, $Billion, 2024-2035
  • Figure 69: South Korea Proteomics Market, $Billion, 2024-2035
  • Figure 70: Rest-of-Asia-Pacific Proteomics Market, $Billion, 2024-2035
  • Figure 71: Brazil Proteomics Market, $Billion, 2024-2035
  • Figure 72: Mexico Proteomics Market, $Billion, 2024-2035
  • Figure 73: Rest-of-Latin America Proteomics Market, $Billion, 2024-2035
  • Figure 74: Data Triangulation
  • Figure 75: Top-Down and Bottom-Up Approach
  • Figure 76: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Partnerships and Collaborations in the Global Proteomics Market
  • Table 4: Global Proteomics Market, Product Benchmarking (by Technology)
  • Table 5: Global Proteomics Market (by Region), $Billion, 2024-2035
  • Table 6: North America Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 7: North America Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 8: North America Proteomics Market (by Application), $Billion, 2024-2035
  • Table 9: U.S. Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 10: U.S. Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 11: U.S. Proteomics Market (by Application), $Billion, 2024-2035
  • Table 12: Canada Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 13: Canada Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 14: Canada Proteomics Market (by Application), $Billion, 2024-2035
  • Table 15: Europe Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 16: Europe Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 17: Europe Proteomics Market (by Application), $Billion, 2024-2035
  • Table 18: U.K. Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 19: U.K. Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 20: U.K. Proteomics Market (by Application), $Billion, 2024-2035
  • Table 21: Germany Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 22: Germany Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 23: Germany Proteomics Market (by Application), $Billion, 2024-2035
  • Table 24: France Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 25: France Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 26: France Proteomics Market (by Application), $Billion, 2024-2035
  • Table 27: Italy Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 28: Italy Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 29: Italy Proteomics Market (by Application), $Billion, 2024-2035
  • Table 30: Spain Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 31: Spain Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 32: Spain Proteomics Market (by Application), $Billion, 2024-2035
  • Table 33: Rest-of-Europe Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 34: Rest-of-Europe Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 35: Rest-of-Europe Proteomics Market (by Application), $Billion, 2024-2035
  • Table 36: Asia-Pacific Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 37: Asia-Pacific Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 38: Asia-Pacific Proteomics Market (by Application), $Billion, 2024-2035
  • Table 39: Japan Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 40: Japan Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 41: Japan Proteomics Market (by Application), $Billion, 2024-2035
  • Table 42: China Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 43: China Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 44: China Proteomics Market (by Application), $Billion, 2024-2035
  • Table 45: India Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 46: India Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 47: India Proteomics Market (by Application), $Billion, 2024-2035
  • Table 48: Australia Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 49: Australia Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 50: Australia Proteomics Market (by Application), $Billion, 2024-2035
  • Table 51: South Korea Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 52: South Korea Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 53: South Korea Proteomics Market (by Application), $Billion, 2024-2035
  • Table 54: Rest-of-Asia-Pacific Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 55: Rest-of-Asia-Pacific Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 56: Rest-of-Asia-Pacific Proteomics Market (by Application), $Billion, 2024-2035
  • Table 57: Latin America Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 58: Latin America Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 59: Latin America Proteomics Market (by Application), $Billion, 2024-2035
  • Table 60: Brazil Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 61: Brazil Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 62: Brazil Proteomics Market (by Application), $Billion, 2024-2035
  • Table 63: Mexico Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 64: Mexico Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 65: Mexico Proteomics Market (by Application), $Billion, 2024-2035
  • Table 66: Rest-of-Latin America Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 67: Rest-of-Latin America Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 68: Rest-of-Latin America Proteomics Market (by Application), $Billion, 2024-2035
  • Table 69: Middle East and Africa Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 70: Middle East and Africa Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 71: Middle East and Africa Proteomics Market (by Application), $Billion, 2024-2035